Institute of Pharmacology

Institute of Pharmacology

Prof. Dr. med. Dobromir Dobrev
Geschäftsführender Direktor
Institutsgruppe 1, 1. OG, Raum 3
Tel.: +49  (0) 201 723 85551        
Fax.: +49 (0) 201 723 5593

Group Photo Essen Jan 2020

Our mission is to explore the fundamental mechanisms underlying cardiovascular diseases and to clarify how specific molecular alterations in cardiac cells and disease-related remodeling cause electrical instability and generate arrhythmias and to apply this knowledge to develop new mechanism-based therapeutic approaches.



July 2020

The group of Prof. Dobrev, director of the Institute of Pharmacology, in collaboration with a group of national and international collaborators, published a study in Circulation Research (Heijman, J. & Muna, AP. et al., Circ Res 2020; published online on July 30), showing for the first time that atrial myocyte NLRP3/CaMKII nexus forms a substrate for post-operative atrial fibrillation.

> more news

Research grants